Veterinary Medicine Information website

Nobivac DHPPi liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai suņiem

Authorised
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
Download as PDF

Product identification

Medicine name:
Nobivac DHPPi liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai suņiem
Active substance:
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Onderstepoort, Live
    10000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    10000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Canine parainfluenza virus, strain Cornell, Live
    316228.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Canine parvovirus, strain 154, Live
    10000000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia

Additional information

Entitlement type:
  • Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/I/26/0017
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
  • Vetzone Limited
Destination wholesaler:
  • Magnum Veterinarija SIA